TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT06818084
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT06818084
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06818084. Non-randomized; no masking; primary purpose treatment. Start 2025-04-29 (actual); primary completion 2027-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System
- Acronym
- TRAMPERS
- Condition
- AORTIC VALVE DISEASES
- Condition
- Aortic Regurgitation
- Intervention (Combination product)
- VitaFlow+GDMT
- Intervention (Combination product)
- J-Valve+GDMT
- Lead sponsor
- Ruijin Hospital
Record details
- Record id
cardio:ct-nct06818084- Content hash
2a0818c46ef4b3cf6fd5c50d43601802b548fdc9d643692eebfa162ac35b74e8